Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/19/25
End: 04/30/31
Due: 04/30/32
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 07/01/27
Due: 07/01/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment | NCT06923176 | Zhiyun Yang | user2@example.com | None | 2025-04-19 | 2031-04-30 | 2032-04-30 | - | - | 2025-07-14 |
| Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study | NCT07017426 | Zhiyun Yang | user2@example.com | None | 2025-07-01 | 2027-07-01 | 2028-07-01 | - | - | 2025-07-14 |